The Valley Desk

NCT02071888 · Interventional trial

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Overall registry status Completed

Phase 1

Conditions Multiple Myeloma, Non-Hodgkin's Lymphoma (NHL), Other B-cell NHL Subtypes, Including WM, T-cell NHL, Waldenstrom's Macroglobulinemia (WM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov